Anti-eIF4A3 antibody [EPR14302(B)] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal eIF4A3 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
DDX48, KIAA0111, EIF4A3, Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, ATP-dependent RNA helicase DDX48, ATP-dependent RNA helicase eIF4A-3, DEAD box protein 48, Eukaryotic initiation factor 4A-like NUK-34, Eukaryotic translation initiation factor 4A isoform 3, Nuclear matrix protein 265, NMP 265, hNMP 265
- WB
Supplier Data
Western blot - Anti-eIF4A3 antibody [EPR14302(B)] - BSA and Azide free (AB250217)
This data was developed using ab180519, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-eIF4A3 antibody [EPR14302(B)] (<a href='/en-us/products/primary-antibodies/eif4a3-antibody-epr14302b-ab180519'>ab180519</a>) at 1/10000 dilution
Lane 1:
MCF7 cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Lane 3:
Raji cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated antibody at 1/1000 dilution
Predicted band size: 47 kDa
false
- WB
Lab
Western blot - Anti-eIF4A3 antibody [EPR14302(B)] - BSA and Azide free (AB250217)
Blocking and dilution buffer : 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab180519).
All lanes:
Western blot - Anti-eIF4A3 antibody [EPR14302(B)] (<a href='/en-us/products/primary-antibodies/eif4a3-antibody-epr14302b-ab180519'>ab180519</a>) at 1/1000 dilution
Lane 1:
eIF4A1 Human Recombinant Protein at 10 ng
Lane 2:
eIF4A2 Human Recombinant Protein at 10 ng
Lane 3:
eIF4A3 Human Recombinant Protein at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 46 kDa
Observed band size: 50 kDa
false
Exposure time: 5s
Related conjugates and formulations (1)
-
Anti-eIF4A3 antibody [EPR14302(B)]
Reactivity data
Product details
ab250217 is the carrier-free version of ab180519.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4A3 engages in nonsense-mediated mRNA decay and plays a role in mRNA splicing. It is an important component of the exon junction complex (EJC) which includes other proteins like MAGOH and Y14. This complex ensures proper mRNA surveillance by marking transcripts that need to be subject to degradation if errors are found.
Pathways
EIF4A3 interacts with cellular processes such as mRNA surveillance and splicing. It integrates within the nonsense-mediated decay (NMD) pathway and the spliceosome-associated pathways. eIF4A3's activity closely relates to proteins like UPF1 and RNPS1 which coordinate the removal of defective mRNA and support mRNA splicing.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 20:361 PubMed33133261
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com